Home / Business and Economy / Hims & Hers Soars on Novo Nordisk Deal

Hims & Hers Soars on Novo Nordisk Deal

9 Mar

Summary

Hims & Hers shares surged due to a report on Novo Nordisk.
Live Nation settled an antitrust case, paying $200 million.
Vertiv, Lumentum, Coherent, EchoStar join S&P 500.

Hims & Hers Health (HIMS) saw its stock price climb significantly today. This surge is reportedly due to an agreement with Novo Nordisk, where the pharmaceutical giant will distribute its weight-loss drugs via the telehealth company's platform, concluding a prior public disagreement.

In other market news, Live Nation Entertainment (LYV) experienced an increase in its share value. This rise follows a report indicating that the company has reached a settlement with the Department of Justice concerning its antitrust case. As part of the agreement, Live Nation will pay $200 million in damages to states that participated in the settlement.

Furthermore, S&P Dow Jones Indices announced that Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar (SATS) are scheduled to be included in the S&P 500 index. This inclusion signifies a notable change in the composition of the widely followed benchmark.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.